COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 1569: Articles 15681-15690  | Next

First comparison of conventional activated sludge versus root-zone treatment for SARS-CoV-2 RNA removal from wastewaters: statistical and temporal significance
Kumar, M., Joshi, M., Kuroda, K., Bhattacharya, P., Barcello, D.
10.1101/2021.05.09.21256898 — Posted: 2021-05-14
SARS-CoV-2 lineage dynamics in England from January to March 2021 inferred from representative community samples
Eales, O., Page, A., Tang, S. N., Walters, C. E., Wang, H., Haw, D., Trotter, A. J., Le Viet, T., Foster-Nyarko, E., Prosolek, S., Atchinson, C., Ashby, D., Cooke, G., Barclay, W., Donnelly, C. A., O'Grady, J., Volz, E., The COVID-19 Genomics UK (COG-UK) Consortium, , Darzi, A., Ward, H., Elliott, P., Riley, S.
10.1101/2021.05.08.21256867 — Posted: 2021-05-14
Systematic Testing for SARS-CoV-2 Infection Among Essential Workers in Montreal, Canada: A Prospective Observational and Cost Assessment Study
Campbell, J. R., Dion, C., Uppal, A., Yansouni, C. P., Menzies, D.
10.1101/2021.05.12.21256956 — Posted: 2021-05-14
A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19
Sivapalasingam, S., Lederer, D., Bhore, R., Hajizadeh, N., Criner, G., Hossain, R., Mahmood, A., Giannelou, A., Somersan-Karakaya, S., O'Brien, M., Boyapati, A., Parrino, J., Musser, B., Labriola-Tompkins, E., Ramesh, D., Purcell, L., Gulabani, D., Kampman, W., Waldron, A., Ng Gong, M., Saggar, S., Sperber, S., Menon, V., Stein, D., Sobieszczyk, M., Park, W., Aberg, J., Brown, S., Kosmicki, J., Horowitz, J., Ferreira, M., Baras, A., Kowal, B., DiCioccio, A. T., Akinlade, B., Nivens, M., Braunstein, N., Herman, G., Yancopoulos, G., Weinreich, D., Sarilumab-COVID-19 Study Team
10.1101/2021.05.13.21256973 — Posted: 2021-05-14
Seroconversion rates following COVID-19 vaccination amongst patients with malignant disease- the impact of diagnosis and cancer-directed therapies
Thakkar, A., Gonzalez Lugo, J., Goradia, N., Gali, R., Shapiro, L. C., Pradhan, K., Rahman, S., Kim, S. Y., Ko, B., Sica, R. A., Kornblum, N., Bachier-Rodriguez, L., McCort, M., Goel, S., Perez-Soler, R., Packer, S., Sparano, J., Gartrell, B., Makower, D., Goldstein, Y. D., Wolgast, L., Verma, A., Halmos, B.
10.1101/2021.05.07.21256824 — Posted: 2021-05-14
The impact of COVID-19 non-pharmaceutical interventions on the lived experience of people living in Thailand, Malaysia, Italy and the United Kingdom: a cross-country qualitative study
Schneiders, M. L., Naemiratch, B., Cheah, P. K., Cuman, G., Poomchaichote, T., Ruangkajorn, S., Stoppa, S., Osterrieder, A., Cheah, P.-K., Ongkili, D., Pan-ngum, W., Mackworth-Young, C., Cheah, P. Y.
10.1101/2021.05.13.21257162 — Posted: 2021-05-14
Impact of the COVID-19 pandemic on the mental health and wellbeing of parents with young children: a qualitative interview study
Dawes, J., May, T., McKinlay, A. R., Fancourt, D., Burton, A.
10.1101/2021.05.13.21256805 — Posted: 2021-05-14 Discussion: Onsite
Cardiovascular vulnerability predicts hospitalisation in primary care clinically suspected and confirmed COVID-19 patients: a model development and validation study
van Royen, F. S., Joosten, L. P., van Smeden, M., Rutten, F. H., Geersing, G.-J., van Doorn, S.
10.1101/2021.05.12.21257075 — Posted: 2021-05-14
Risk of COVID-19 epidemic resurgence with the introduction of vaccination passes
Krueger, T., Gogolewski, K., Bodych, M., Gambin, A., Giordano, G., Cuschieri, S., Czypionka, T., Perc, M., Petelos, E., Rosinska, M., Szczurek, E.
10.1101/2021.05.07.21256847 — Posted: 2021-05-14
Analysis of 472,688 severe cases of COVID-19 in Brazil showed lower mortality in those vaccinated against influenza
Sardinha, D. M., Lobato, D. d. C., Ferreira, A. L. d. S., Lima, K. V. B., Guimaraes, R. J. d. P. S. e., Lima, L. N. G. C.
10.1101/2021.05.11.21257053 — Posted: 2021-05-14 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).